Prospective comparison of uPA/PAI-1 and EndoPredict-clin score in ER-positive, HER2-negative breast cancer: Impact on risk stratification and treatment decisions.
Johannes Ettl
No relevant relationships to disclose
Kirsten Grosse Lackmann
No relevant relationships to disclose
Alexander Hapfelmeier
No relevant relationships to disclose
Evelyn Klein
No relevant relationships to disclose
Stefan Paepke
No relevant relationships to disclose
Christoph Petry
Employment or Leadership Position - Sividon Diagnostics
Stock Ownership - Sividon Diagnostics
Katja Specht
No relevant relationships to disclose
Heinz Hoefler
No relevant relationships to disclose
Marion Kiechle
Honoraria - Sividon Diagnostics
Research Funding - Sividon Diagnostics